DNA Script inks $200m Series C
DNA Script, a provider of enzymatic DNA synthesis for on-demand DNA printing, has raised $200 million in Series C financing.
DNA Script, a provider of enzymatic DNA synthesis for on-demand DNA printing, has raised $200 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination